Table 2 |
||||
|
Statistics of sp3 stereochemical content in the KEGG Compound and BioMeta databases |
||||
|
Stereochemistry |
OK |
# in KEGG |
# in BioMeta |
# Corrected |
|
|
||||
|
Not possible |
+ |
3725 |
3764 |
|
|
Undefined (i.e., omitted) |
– |
554 |
366 |
188 |
|
Incompletely defined – meso |
– |
24 |
3 |
21 |
|
Incompletely defined – absolute |
– |
1080 |
691 |
389 |
|
Incompletely defined – relative |
– |
294 |
171 |
123 |
|
Completely defined – meso |
+ |
56 |
89 |
|
|
Completely defined – absolute |
+ |
3735 |
4823 |
|
|
Completely defined – relative |
– |
2032 |
1669 |
363 |
|
Total not OK |
3984 |
2900 |
1084 |
|
|
Total OK |
7516 |
8676 |
||
|
Total |
11500 |
11576 |
||
|
|
||||
|
The numbers in this table give a more detailed breakdown of the sp3 stereochemistry enhancements from Table 1. Here "OK" means a single, completely defined, compound. The "unspecified enantiomer" cases from Table 1 are split here between two "relative" stereochemistry cases, incompletely and completely defined. Note that not all "Completely defined – relative" cases need to be errors – a number of drugs may be racemic compounds. |
||||
|
Ott and Vriend BMC Bioinformatics 2006 7:517 doi:10.1186/1471-2105-7-517 |
||||